Dermatology

One-year Phase III data show icotrokinra delivered durable skin clearance and symptom improvement in adults with moderate-to-severe plaque psoriasis.

Adding oral GP-SOD to targeted UVB phototherapy significantly improved repigmentation and quality of life in patients with localized vitiligo.

A network meta-analysis found topical ivermectin and encapsulated benzoyl peroxide were more effective than metronidazole for moderate-to-severe rosacea.

Reduced infant bathing frequency was associated with lower eczema rates at six months in a feasibility trial, suggesting a potential prevention approach.

LEO Pharma has acquired Replay’s herpes simplex virus gene therapy platform for $50m upfront.

A randomised trial found online team-based telehealth delivered similar improvements to in-person care for patients with atopic dermatitis.

A proteomic study reveals how paroxetine may improve refractory rosacea by influencing neurovascular-immune pathways and identifying potential treatment biomarkers.

A systematic review compares fractional CO₂ laser and needling treatments for acne scars, assessing effectiveness, safety, and treatment-related risks.